|
|
Article: Human Genome Sciences and Medarex Announce Collaboration.
- Article from:
- PR Newswire
- Article date:
- July 25, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
- Medarex's Fully Human Antibodies Expected to be Used As
Novel Drugs for Human Genome Sciences -
ROCKVILLE, Md., and PRINCETON, N.J., July 25 /PRNewswire/ --
Human Genome Sciences, Inc. (Nasdaq: HGSI) and Medarex, Inc. ("Medarex") (Nasdaq: MEDX) today announced that they have entered an agreement whereby the parties intend to use Medarex's technology to create fully human antibodies for commercialization by Human Genome Sciences. Under the agreement Human Genome Sciences has an option to exclusively license therapeutic and diagnostic antibody products resulting from the collaboration. Medarex is entitled to receive license fees, milestone ...